Google
Apple
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
GE HEALTHCARE TECHNOLOGIES INC. GE HealthCare Technologies Inc. Stock price
Equities
GEHC
US36266G1076
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
|
Pre-market 07:40:27 am | ||
| 68.52 USD | +1.68% | 68.99 | +0.69% | |
Financials (USD)
| Sales 2023 * | 19.41B | Sales 2024 * | 20.3B | Capitalization | 31.19B |
|---|---|---|---|---|---|
| Net income 2023 * | 1.59B | Net income 2024 * | 1.86B | EV / Sales 2023 * | 1,92x |
| Net Debt 2023 * | 6.05B | Net Debt 2024 * | 4.25B | EV / Sales 2024 * | 1,75x |
| P/E ratio 2023 * | 20,4x | P/E ratio 2024 * | 17,1x | Employees | 50,000 |
| Yield 2023 * | 0,19% | Yield 2024 * | 0,26% | Free-Float | 99.93% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +1.68% | ||
| 1 week | -1.28% | ||
| Current month | +0.09% | ||
| 1 month | -1.44% | ||
| 3 months | +5.58% | ||
| 6 months | -11.13% | ||
| Current year | +17.37% |
1 week
67.00
69.05
1 month
66.3974.18
Current year
53.5087.83
1 year
53.0087.83
3 years
53.0087.83
5 years
53.0087.83
10 years
53.0087.83
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.26% | 45 M€ | +14.58% | ||
| 3.37% | 5 M€ | +17.00% | ||
| 2.61% | 58 M€ | -13.15% | - | |
| 2.54% | 4,371 M€ | -3.65% | ||
| 2.14% | 131 M€ | -1.53% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-08 | 68.52 | +1.68% | 1,893,851 |
| 23-12-07 | 67.39 | -0.97% | 2,089,189 |
| 23-12-06 | 68.05 | +0.18% | 1,579,722 |
| 23-12-05 | 67.93 | -2.08% | 1,896,265 |
| 23-12-04 | 69.37 | -0.06% | 1,478,766 |
Delayed Quote Nasdaq, December 08, 2023 at 04:00 pm EST
More quotes
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company's segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
Calendar
2024-01-28
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
68.52USD
Average target price
83.04USD
Spread / Average Target
+21.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.37% | 31 193 M $ | |
| -11.06% | 189 B $ | |
| -18.06% | 161 B $ | |
| +16.99% | 109 B $ | |
| +18.76% | 80 501 M $ | |
| +12.01% | 63 269 M $ | |
| -6.32% | 49 971 M $ | |
| -7.28% | 41 958 M $ | |
| -15.00% | 37 158 M $ | |
| -21.75% | 23 955 M $ |
